Stockscreener 앱 받기
10.37
5.12%
-0.56
전일 마감가:
$10.93
열려 있는:
$10.78
하루 거래량:
283.93K
Relative Volume:
0.88
시가총액:
$550.54M
수익:
-
순이익/손실:
$-83.74M
주가수익비율:
-6.441
EPS:
-1.61
순현금흐름:
$-64.98M
1주 성능:
-6.24%
1개월 성능:
+6.69%
6개월 성능:
-28.28%
1년 성능:
-51.79%
1일 변동 폭
$10.33
$10.81
1주일 범위
$10.33
$11.66
52주 변동 폭
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
명칭
Tyra Biosciences Inc
전화
(619) 728-4760
주소
2656 STATE STREET, CARLSBAD
TYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.37 | 581.24M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-21 | 재개 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | UBS | Buy |
| 2024-10-18 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-08-15 | 개시 | Piper Sandler | Overweight |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-30 | 개시 | Wedbush | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-06-23 | 개시 | H.C. Wainwright | Buy |
| 2022-03-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Jefferies | Buy |
모두보기
Tyra Biosciences Inc 주식(TYRA)의 최신 뉴스
How to integrate Tyra Biosciences Inc. into portfolio analysis toolsShort-Term Price Breakout Signal Analysis - Newser
Combining price and volume data for Tyra Biosciences Inc.Risk Balanced Picks for Safer Trading - Newser
Why is Tyra Biosciences Inc. stock attracting strong analyst attentionStock Strategy Target Finder From AI Tools - jammulinksnews.com
What is the risk reward ratio of investing in Tyra Biosciences Inc. stockAdvanced Screener Alerts That Work - jammulinksnews.com
Technical analysis overview for Tyra Biosciences Inc. stockEntry Optimization Tool with Screener Logic - Newser
Is it the right time to buy Tyra Biosciences Inc. stockSwing Trade Updates For Consistent Profits - jammulinksnews.com
What moving averages say about Tyra Biosciences Inc.Reversal Pattern Insights with Entry Tips - Newser
What machine learning models say about Tyra Biosciences Inc.Daily Upside Movement Prediction With Data - Newser
What institutional flow reveals about Tyra Biosciences Inc.Free Access to Real-Time Trade Insights - Newser
What makes Tyra Biosciences Inc. stock attractive to long term investorsRapid Trade Forecast Based on Indicators - Newser
How to recover losses in Tyra Biosciences Inc. stockDownside Risk Evaluation and Stock Analysis - Newser
Intrahepatic Cholangiocarcinoma Pipeline Insight 2025: 20+ - openPR.com
Intrahepatic Cholangiocarcinoma Pipeline Insight 2025: 20+ Emerging Therapies Target FGFR2, IDH1/2, and Beyond | DelveInsight - The Globe and Mail
Relative strength of Tyra Biosciences Inc. in sector analysisEarly Entry Ideas with Momentum Potential - Newser
Can Tyra Biosciences Inc. recover in the next quarterStock Trading Session Highlights and Summary - Newser
What risks could impact Tyra Biosciences Inc. stock performanceReal Market Tracker with Price Action Tools - Newser
What indicators show strength in Tyra Biosciences Inc.Free Price Action Based Buy Opportunity List - Newser
Will Tyra Biosciences Inc. stock benefit from AI tech trendsExpert-Backed High Yield Stock Watchlist - Newser
Is this a good reentry point in Tyra Biosciences Inc.Real-Time Entry Forecast with Accuracy Metrics - Newser
Non-Muscle Invasive Bladder Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Prokarium Ltd., Vaxiion Therapeutics, Tyra Biosciences, Lipac - Barchart.com
How Resilient Is Tyra Biosciences Inc. Stock During Economic DownturnsShort Term Profit Strategy with Entry Cues - Newser
Advanced analytics toolkit walkthrough for Tyra Biosciences Inc.Free Low Drawdown Real Time Trading Tips - Newser
What makes Tyra Biosciences Inc. stock price move sharplyTechnical Trade Plan with Entry Checklist - Newser
Why Tyra Biosciences Inc. stock attracts strong analyst attentionFree Breakout Momentum Picks With Protection - Newser
How Tyra Biosciences Inc. stock performs during market volatilityLong Hold Investment Strategy with Growth Focus - Newser
Tyra Biosciences Inc. Recovery Likely Here’s What Data ShowsTop Performing Stock Insights Released Daily - metal.it
Tyra Biosciences Inc. stock chart pattern explainedDaily Market Momentum Summary and Strategy - Newser
When is Tyra Biosciences Inc. stock expected to show significant growthWealth Building Trend Scanner For Smart Trading - jammulinksnews.com
What are analysts’ price targets for Tyra Biosciences Inc. in the next 12 monthsStock Strategy Insights For Fast Growth - jammulinksnews.com
Does Tyra Biosciences Inc. stock perform well during market downturnsCapitalize on market trends with expert guidance - jammulinksnews.com
How does Tyra Biosciences Inc. generate profit in a changing economyAchieve consistent high returns with low risk - jammulinksnews.com
Is this a good reentry point in Tyra Biosciences Inc. Deep Stock Performance and Volatility Analysis - Newser
How Tyra Biosciences Inc. stock performs during market volatility Market Forecast Summary Over Multi-Year Period - Newser
How does Tyra Biosciences Inc. compare to its industry peersUnlock powerful stock screening techniques - jammulinksnews.com
Tyra Biosciences Inc (TYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tyra Biosciences Inc 주식 (TYRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KAPLAN GILLA | Director |
Jun 17 '25 |
Sale |
10.35 |
10 |
104 |
37,799 |
0.93%
0.15%
자본화:
|
볼륨(24시간):